BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9823326)

  • 1. The anti-MUC1 monoclonal antibody BCP8 can be used to isolate and identify putative major histocompatibility complex class I associated amino acid sequences.
    Agrawal B; Reddish MA; Christian B; VanHeele A; Tang L; Koganty RR; Longenecker BM
    Cancer Res; 1998 Nov; 58(22):5151-6. PubMed ID: 9823326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
    Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
    Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cells recognize PD(N/T)R motif common in a variable number of tandem repeat and degenerate repeat sequences of MUC1.
    Pisarev VM; Kinarsky L; Caffrey T; Hanisch FG; Sanderson S; Hollingsworth MA; Sherman S
    Int Immunopharmacol; 2005 Feb; 5(2):315-30. PubMed ID: 15652762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic identification of an MHC-binding peptidome from pancreas and breast cancer cell lines.
    Antwi K; Hanavan PD; Myers CE; Ruiz YW; Thompson EJ; Lake DF
    Mol Immunol; 2009 Sep; 46(15):2931-7. PubMed ID: 19615748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
    Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
    J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes.
    Ogg GS; Dunbar PR; Cerundolo V; McMichael AJ; Lemoine NR; Savage P
    Br J Cancer; 2000 Mar; 82(5):1058-62. PubMed ID: 10737389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wild-type p53 epitope naturally processed and presented by an HLA-B haplotype on human breast carcinoma cells.
    Papadopoulos KP; Hesdorffer CS; Suciu-Foca N; Hibshoosh H; Harris PE
    Clin Cancer Res; 1999 Aug; 5(8):2089-93. PubMed ID: 10473091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of HLA-A2-restricted CTLs to the mucin 1 human breast cancer antigen.
    Apostolopoulos V; Karanikas V; Haurum JS; McKenzie IF
    J Immunol; 1997 Dec; 159(11):5211-8. PubMed ID: 9548459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presentation of MUC1 tumor antigen by class I MHC and CTL function correlate with the glycosylation state of the protein taken Up by dendritic cells.
    Hiltbold EM; Alter MD; Ciborowski P; Finn OJ
    Cell Immunol; 1999 Jun; 194(2):143-9. PubMed ID: 10383817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human single-chain Fv antibodies to MUC1 core peptide selected from phage display libraries recognize unique epitopes and predominantly bind adenocarcinoma.
    Henderikx P; Kandilogiannaki M; Petrarca C; von Mensdorff-Pouilly S; Hilgers JH; Krambovitis E; Arends JW; Hoogenboom HR
    Cancer Res; 1998 Oct; 58(19):4324-32. PubMed ID: 9766660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUC1-derived glycopeptide libraries with improved MHC anchors are strong antigens and prime mouse T cells for proliferative responses to lysates of human breast cancer tissue.
    Gad M; Jensen T; Gagne R; Komba S; Daugaard S; Kroman N; Meldal M; Werdelin O
    Eur J Immunol; 2003 Jun; 33(6):1624-32. PubMed ID: 12778480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
    Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
    Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides.
    Wei ML; Cresswell P
    Nature; 1992 Apr; 356(6368):443-6. PubMed ID: 1557127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1-specific CD8+ T cells identified by peptide-MHC-class-I tetramers.
    Bohnenkamp HR; Coleman J; Burchell JM; Taylor-Papadimitriou J; Noll T
    Cell Immunol; 2004; 231(1-2):112-25. PubMed ID: 15919376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HLA-E mAb 3D12 mimics MEM-E/02 in binding to HLA-B and HLA-C alleles: Web-tools validate the immunogenic epitopes of HLA-E recognized by the antibodies.
    Ravindranath MH; Pham T; El-Awar N; Kaneku H; Terasaki PI
    Mol Immunol; 2011 Jan; 48(4):423-30. PubMed ID: 21145594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCR mimic monoclonal antibody targets a specific peptide/HLA class I complex and significantly impedes tumor growth in vivo using breast cancer models.
    Verma B; Neethling FA; Caseltine S; Fabrizio G; Largo S; Duty JA; Tabaczewski P; Weidanz JA
    J Immunol; 2010 Feb; 184(4):2156-65. PubMed ID: 20065111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-MUC1 antibodies react directly with MUC1 peptides presented by class I H2 and HLA molecules.
    Apostolopoulos V; Chelvanayagam G; Xing PX; McKenzie IF
    J Immunol; 1998 Jul; 161(2):767-75. PubMed ID: 9670953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 gene.
    Hogan KT; Eisinger DP; Cupp SB; Lekstrom KJ; Deacon DD; Shabanowitz J; Hunt DF; Engelhard VH; Slingluff CL; Ross MM
    Cancer Res; 1998 Nov; 58(22):5144-50. PubMed ID: 9823325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes.
    Maeurer MJ; Chan HW; Karbach J; Salter RD; Knuth A; Lotze MT; Storkus WJ
    Eur J Immunol; 1996 Nov; 26(11):2613-23. PubMed ID: 8921947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antibody recognition of synthetic antigens from MUC1.
    Bánóczi Z; Mezõ G; Windberg E; Uray K; Majer Z; Hudecz F
    J Pept Sci; 2008 May; 14(5):610-6. PubMed ID: 17975847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.